Free shipping on all orders over $ 500

CFTR corrector 6

Cat. No. M54657

All AbMole products are for research use only, cannot be used for human consumption.

CFTR corrector 6 Structure
Size Price Availability Quantity
10mg USD 800 In stock
25mg USD 1520 In stock
50mg USD 2350 In stock
100mg USD 3400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CFTR corrector 6 is a potent cystic fibrosis transmembrane conductance regulator (CFTR) enhancer for cystic fibrosis (CF) and other CFTR-related diseases.

Chemical Information
Molecular Weight 479.39
Formula C22H13F4N9
CAS Number 2226970-01-8
Form Solid
Solubility (25°C) DMSO 100 mg/mL
Storage 4°C, protect from light
Related CFTR Products
Ataluren

Ataluren (PTC124) is a novel, orally available small molecular CFTR-G542X nonsense allele inhibitor.

VX-770 (Ivacaftor)

VX-770 (Ivacaftor) is a first-in-class potentiator of CFTR, which targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

Lonidamine

Lonidamine (AF-1890) is a novel CFTR open channel blocker with an IC50 of 0.85 mM, which inhibits aerobic glycolysis in cancer cells. Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki=2.5 μM).

VX-809

VX-809 is a CFTR corrector that improves CFTR processing and maturation in the cell.

CFTR(inh)-172

CFTR(inh)-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.

  Catalog
Abmole Inhibitor Catalog




Keywords: CFTR corrector 6 supplier, CFTR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.